Table 2.

Prevalence of pathogens isolated in patients with HAP according to use of early corticosteroid therapy

Risk factor	Overall population (n = 46)	Early corticosteroid therapy (n = 33)	No early corticosteroid therapy (n = 13)
P. aeruginosa	13 (28.3%)	12 (92.3%)	1 (7.7%)
A. baumannii	7 (15.2%)	5 (71.4%)	2 (28.6%)
S. pneumoniae	5 (10.9%)	4 (80.0%)	1 (20.0%)
S. aureus a	5 (10.9%)	2 (25.0%)	3 (75.0%)
Aspergillus spp.	4 (8.7%)	3 (75.0%)	1 (25.0%)
K. pneumoniae	3 (6.5%)	2 (66.7%)	1 (33.3%)
E. coli	2 (4.3%)	2 (100%)	0
H. influenza	2 (4.3%)	2 (100%)	0
E. cloacae	2 (4.3%)	1 (50%)	1 (50%)
E. aerogenes	1 (2.2%)	0	1 (100%)
S. marcescens	1 (2.2%)	0	1 (100%)
S. maltophila	1 (2.2%)	0	1 (100%)

^aIncluding one episode of oxacillin-resistant S. aureus